The main discussion board is in chaos right now. I understand why though. That pharmacy worked well for me even with the inspection issues. I missed the earlier shutdown but I bet the reaction was the same.
Looks like the FDA is pushing its authority once more. One of the larger 503b outsourcing compounders of these medications was a popular source for versions without additives and with extended beyond-use dates. It received a letter telling it to cease making items not on the bulks or shortage lists, though the letter itself has not been released publicly. The facility is following the instruction and told telehealth partners it has only a few days of supply remaining. It had received several prior 483 letters, including one in September of 2025, and it is unclear if the latest action ties back to that inspection.